Alain D. Baron,Dennis Kim,David G. Maggs,Matthew Wintle
申请号：
US12063712
公开号：
US08389472B2
申请日:
2006.08.21
申请国别(地区):
US
年份:
2013
代理人:
摘要：
The present invention relates generally to the novel use of incretin compounds (ICs) and amylinomimetic compounds to treat, prevent, or ameliorate a variety of metabolic conditions or diseases.
